Author

Anne Larocca

Observed names: A P Larocca, A. Larocca

Institution: Biogen (United States)

Observed institutions: Biogen (United States), Artann Laboratories, Inc.

OpenAlex ID: A5079236304

Evaluation of neutralizing antibodies in patients treated with recombinant interferon-beta ser.

1989 · A P Larocca, S C Leung, et al. · PubMed · 43

Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab

2006 · M. S. Czuczman, A. J. Grillo-López, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 26

Anti-CD20 monoclonal antibodies as novel treatments for non-Hodgkin's lymphoma

1999 · Christine A. White, Anne Larocca, et al. · Pharmaceutical Science & Technology Today · 13

Fc-Gamma Receptor IIIa and Interferon-Gamma SNPs Do Not Predict Responsiveness of Follicular Lymphoma to Galiximab (Anti-CD80 Antibody).

2004 · Myron Czuczman, Bryan R. Leigh, et al. · Blood · 4

Works count: 4

Citation count: 86

H-index: 4

I10-index: 3